High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study

NCT03188978 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit

Conditions

Primary Arteriovenous Fistula Failure

Interventions

DRUG: Atorvastatin 40mg
OTHER: Placebo

Sponsor

Albany Medical College